News

Devdiscourse1d
Novavax Booster's Fate in Limbo: FDA Considers Approval Amid Controversy
The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.
Fierce Pharma2d
FDA asks Novavax for post-marketing data pledge amid stalled COVID shot review
On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...
BioSpace2d
RFK Considers Pulling COVID-19 From CDC’s Vaccine Guidelines for Children: Politico
Such a change would put the U.S. more in line with guidance in other countries and with the World Health Organization, which ...
Special Writer, The Wall Street Journal
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...
CDC advisory group considers narrowing COVID vaccine recommendations
Notes from a recent meeting of the CDC’s Advisory Committee on Immunization Practices’ COVID-19 Work Group show health ...
pharmaphorum22d
Moderna follows Pfizer in asking FDA for second COVID booster okay
There's no guidance yet from the CDC or FDA on whether a second booster will be needed. "If Omicron continues circulating and we are still using the current first generation COVID-19 vaccines ...
US CDC advisers discuss narrowing use of COVID-19 booster shots
The U.S. Centers for Disease Control and Prevention's outside panel of vaccine experts on Tuesday discussed narrowing ...